Δ9-Tetrahydrocannabinol targeting estrogen receptor signaling: The possible mechanism of action coupled with endocrine disruption

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 9, 2014, Pages 1435-1438

  Takeda, Shuso ^a  

^a HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Anti estrogen; Estrogen receptor; Marijuana; 9 tetrahydrocannabinol

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; DRONABINOL; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LACTOFERRIN; PESTICIDE; PHYTOESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA, HUMAN;

ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; DNA METHYLATION; ENDOCRINE SYSTEM; ERBETA GENE; GENE; GENE EXPRESSION; HUMAN; LIGAND BINDING; NONHUMAN; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; METABOLISM;

ANIMALS; DRONABINOL; ENDOCRINE DISRUPTORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84906961640     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00226     Document Type: Article

References (43)

1. Galve-Roperh I., Sánchez C, Cortés ML, Gómez del Pulgar T, Izquierdo M, Guzmán M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med., 6, 313-319 (2000).
2. Howlett AC, Barth F, Bonner T.I., Cabral G., Casellas P, Devane WA, Felder C.C., Herkenham M., Mackie K, Martin BR, Mechoulam R, Pertwee RG International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202 (2002).
3. Ligresti A, Moriello AS, Starowicz K, Matias I., Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V. Antitumor activity of plant cannabinoids with emphasis on the effect of can-nabidiol on human breast carcinoma. J. Pharmacol. Exp. Ther., 318, 1375-1387 (2006).
4. 9-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling. Toxicology, 245, 141-146 (2008).
5. 9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase. Toxicology, 259, 25-32 (2009).
6. 2. Pharmacol. Rev., 62, 588-631 (2010).
7. Guindon J, Hohmann AG The endocannabinoid system and cancer: therapeutic implication. Br. J. Pharmacol., 163, 1447-1463 (2011).
8. 9-tetrahydrocannabinol-11-oic acid as 15-lipoxy-genase inhibitors. J. Pharm. Sci., 100, 1206-1211 (2011).
9. 9-tetrahydrocannabinol in human breast cancer cells. J. Toxi col. Sci., 38, 305-308 (2013).
10. 9-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor β (ERβ). Chem. Res. Toxicol., 26, 1073-1079 (2013).
11. Takeda S. Medicinal chemistry and pharmacology focused on can-nabidiol, a major component of the fiber-type cannabis. Yakugaku Zasshi, 133, 1093-1101 (2013).
12. Smith CG, Asch RH Acute, short-term, and chronic effects of marijuana on the female primate reproductive function. NIDA Res. Monogr., 44, 82-96 (1984).
13. Brown TT, Dobs AS Endocrine effects of marijuana. J. Clin. Pharmacol., 42 (Suppl.), 90S-96S (2002).
14. 1-tetrahydrocannabinol. Nature, 243, 470-471 (1973).
15. 9-THC) attenuates mouse sperm motility and male fecundity. Br. J. Pharmacol., 165, 2575-2583 (2012).
16. Lubahn DB, Moyer JS, Golding T.S., Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A., 90, 11162-11166 (1993).
17. Couse JF, Bunch DO, Lindzey J, Schomberg D.W., Korach KS. Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-α knockout mouse. Endocrinology, 140, 5855-5865 (1999).
18. Dupont S, Krust A, Gansmuller A., Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development, 127, 4277-4291 (2000).
19. Saji S, Jensen EV, Nilsson S, Rylander T., Warner M, Gustafsson JA. Estrogen receptors α and β in the rodent mammary gland. Proc. Natl. Acad. Sci. U.S.A., 97, 337-342 (2000).
20. Emmen JM, Couse JF, Elmore S.A., Yates MM, Kissling GE, Korach KS. In vitro growth and ovulation of follicles from ovaries of estrogen receptor (ER)α and ERα null mice indicate a role for ERβ in follicular maturation. Endocrinology, 146, 2817-2826 (2005).
21. Woodruff TK, Mayo KE To β or not to β: estrogen receptors and ovarian function. Endocrinology, 146, 3244-3246 (2005).
22. 9-tetrahydrocannabinol with estrogen in rat uterine estrogen receptor binding. Science, 197, 1189-1191 (1977).
23. 9-Tetrahydrocannabinol and 17β-estradiol bind to different macromolecules in estrogen target tissues. Science, 200, 312-314 (1978).
24. Sauer MA, Rifka SM, Hawks R.L., Cutler GB Jr, Loriaux DL. Marijuana: interaction with the estrogen receptor. J. Pharmacol. Exp. Ther., 224, 404-407 (1983).
25. Ruh MF, Taylor JA, Howlett A.C., Welshons W V. Failure of cannabi-noid compounds to stimulate estrogen receptors. Biochem. Pharmacol., 53, 35-41 (1997).
26. 1-tetrahydrocannabinol on the steroidogenic activity of rat granulosa cells in culture. Horm. Res., 19, 43-51 (1984).
27. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S., Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A., 93, 5925-5930 (1996).
28. Das SK, Paria BC, Chakraborty I, Dey SK Cannabinoid ligand-re-ceptor signaling in the mouse uterus. Proc. Natl. Acad. Sci. U.S.A., 92, 4332-4336 (1995).
29. Weihua Z, Saji S, Mäkinen S, Cheng G., Jensen EV, Warner M, Gustafsson JA. Estrogen receptor (ER) β, a modulator of ERα in the uterus. Proc. Natl. Acad. Sci. U.S.A., 97, 5936-5941 (2000).
30. Hall JM, McDonnell DP The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and anti-estrogens. Endocrinology, 140, 5566-5578 (1999).
31. Pettersson K, Delaunay F, Gustafsson JA Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene, 19, 4970-4978 (2000).
32. Zhao C, Matthews J, Tujague M., Wan J, Ström A, Toresson G., Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K. Estrogen receptor β2 negatively regulates the transactivation of estrogen receptor α in human breast cancer cells. Cancer Res., 67, 3955-3962 (2007).
33. Powell E, Xu W. Intermolecular interactions identify ligand-selective activity of estrogen receptor α/β dimers. Proc. Natl. Acad. Sci. U.S.A., 105, 19012-19017 (2008).
34. Beischlag TV, Luis Morales J, Hollingshead BD, Perdew GH The aryl hydrocarbon receptor complex and the control of gene expression. Crit. Rev. Eukaryot. Gene Expr., 18, 207-250 (2008).
35. Wormke M, Stoner M, Saville B., Safe S. Crosstalk between estrogen receptor α and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes. FEBS Lett., 478, 109-112 (2000).
36. Safe S, Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor α cross-talk and mechanisms of action. Chem. Res. Toxicol., 16, 807-816 (2003).
37. Ahmed S, Valen E, Sandelin A., Matthews J. Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor α at human promoters. Toxicol. Sci., 111, 254-266 (2009).
38. 9-tetrahydrocannabinol. Am. J. Respir. Cell Mol. Biol., 24, 339-344 (2001).
39. Zhao C, Lam EW, Sunters A, Enmark E., De Bella MT, Coombes RC, Gustafsson JA, Dahlman-Wright K. Expression of estrogen receptor β isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene, 22, 7600-7606 (2003).
40. Bardin A, Boulle N, Lazennec G., Vignon F, Pujol P. Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer, 11, 537-551 (2004).
41. Rody A, Holtrich U, Solbach C., Kourtis K, von Minckwitz G, Engels K, Kissler S., Gätje R, Karn T., Kaufmann M. Methylation of estrogen receptor β promoter correlates with loss of ER-β expression in mammary carcinoma and is an early indication marker in premalignant lesions. Endocr. Relat. Cancer, 12, 903-916 (2005).
42. McKallip RJ, Nagarkatti M, Nagarkatti PS Δ-9-Tetrahydro-cannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol., 174, 3281-3289 (2005).
43. 1-tetrahydrocannabinol in human fat biopsies from marijuana users by gas chromatography-mass spectrometry. Biomed. Chromatogr., 3, 35-38 (1989).